Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Vimal Mehta

Vimal Mehta is recorded as CEO at BioXcel Therapeutics, Inc. (BTAIQ). The proxy statement of BioXcel Therapeutics, Inc. reports total compensation of $1,119,245 for Vimal Mehta in fiscal 2024, including a base salary of $1,001,570. Disclosed compensation is on record for 7 fiscal years. Vimal Mehta has spoken on 9 earnings calls and 1 other investor event across 1 company, most recently for BioXcel Therapeutics, Inc. on August 27, 2025.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at BioXcel Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 BioXcel Therapeutics, Inc. (BTAIQ) $1,001,570 $1,119,245
2023 BioXcel Therapeutics, Inc. (BTAIQ) $1,001,569 $4,731,147
2022 BioXcel Therapeutics, Inc. (BTAIQ) $944,436 $4,559,195
2021 BioXcel Therapeutics, Inc. (BTAIQ) $916,701 $9,372,177
2020 BioXcel Therapeutics, Inc. (BTAIQ) $890,000 $9,576,550
2019 BioXcel Therapeutics, Inc. (BTAIQ) $459,000 $1,968,931
2018 BioXcel Therapeutics, Inc. (BTAIQ) $423,359 $701,609

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.